MedPath

Effect Of Ursodeoxycholic Acid on indirect Hyperbilirubinemia in Neonates Treated with phototherapy

Phase 1
Conditions
Hyperbilirubinemia.
defects of catalase and peroxidase
Registration Number
IRCT2017071515511N2
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
220
Inclusion Criteria

Admission criteria: Neonates with nonconjunctive Hyperbilirubinemia weighing 2500-4000 gr; Breastfeeding, 37-41w GA; Age greater than 24h; Tbili = 14-20; Dbili <2mg / dl
Exit criteria: Inconsistency of ABO, RH, G6PD negative; Negative septicemia; Diseases leading to Hyperbilirubinemia: Carpenter Najjar, Gilbert, Hyperthyroid hypertrophic hypothyroidism, Preterm and diabetic mothers

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate Tbili. Timepoint: 0, 12, 24 and 48 hours. Method of measurement: Spectrophotometry.
Secondary Outcome Measures
NameTimeMethod
Rate BG , RH , TSH. Timepoint: first day. Method of measurement: blood test.
© Copyright 2025. All Rights Reserved by MedPath